Literature DB >> 14760989

Primary thymic adenocarcinoma with production of carbohydrate antigen 19-9 and carcinoembryonic antigen.

Takahiko Misao1, Yosuke Yamamoto, Hideharu Nakano, Shinichi Toyooka, Masataka Yamane, Katashi Satoh.   

Abstract

A 59-year-old male, whose chest X-ray showed an abnormal shadow, visited us for further study. Laboratory examination showed the elevated level for both carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) in serum, and the chest X-ray and computed tomography showed an anterior mediastinal mass. Under a diagnosis of thymic malignancy, extended thymectomy with combined resection of the pleura and pericardium was performed. Histopathological findings showed a well-differentiated adenocarcinoma of the thymus, in which CA19-9 and CEA were positive immuno-histochemically. The level of serum CA19-9 and CEA returned to normal ranges postoperatively, however, the tumor recurred in local site with re-elevation of these tumor markers at the 20th month after surgery. He died at 4th month after the first recurrence despite the intensive chemotherapy. We report an extremely rare case of primary thymic adenocarcinoma with the production of CA19-9 and CEA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760989     DOI: 10.1007/s11748-004-0058-3

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  8 in total

1.  Thymic carcinoma: spectrum of differentiation and histologic types.

Authors:  S Suster; C A Moran
Journal:  Pathology       Date:  1998-05       Impact factor: 5.306

2.  [A case of adenocarcinoma of the thymus].

Authors:  Y Makino; M Asada; T Suzuki; M Hashimoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-11

3.  Thymic hyperplasia and neoplasia: a review of current concepts.

Authors:  G D Levine; J Rosai
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

4.  Thymic carcinoma. A clinicopathologic study of 13 cases.

Authors:  L D Truong; D R Mody; P T Cagle; G L Jackson-York; M R Schwartz; T M Wheeler
Journal:  Am J Surg Pathol       Date:  1990-02       Impact factor: 6.394

Review 5.  Primary carcinomas of the thymus gland.

Authors:  J H Ritter; M R Wick
Journal:  Semin Diagn Pathol       Date:  1999-02       Impact factor: 3.464

6.  Successful treatment with concurrent chemoradiotherapy followed by surgery for a patient with thymic adenocarcinoma.

Authors:  M Shimono; A Hiraki; H Ueoka; Y Tanimoto; M Aoe; K Sakae; K Kaneda; M Sakugawa; K Kiura; M Harada
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

7.  Primary thymic carcinomas.

Authors:  M R Wick; B W Scheithauer; L H Weiland; P E Bernatz
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

8.  Thymic carcinoma. A clinicopathologic study of 60 cases.

Authors:  S Suster; J Rosai
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

  8 in total
  4 in total

1.  Thymic adenocarcinoma with sarcomatoid features characterized by intracaval tumor growth: report of a case.

Authors:  Toshiji Ishiwata; Mitsuaki Sekiya; Tsutomu Suzuki; Takashi Matsuoka; Toshio Kumasaka; Kazuhisa Takahashi
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

2.  A Rare Case of Primary Tubular Adenocarcinoma of the Thymus, Enteric Immunophenotype: A Case Study and Review of the Literature.

Authors:  Hae Yoen Jung; Hyundeuk Cho; Jin-Haeng Chung; Sang Byoung Bae; Ji-Hye Lee; Hyun Ju Lee; Si-Hyong Jang; Mee-Hye Oh
Journal:  J Pathol Transl Med       Date:  2015-07-15

3.  Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.

Authors:  Yeonghun Lee; Sehhoon Park; Se-Hoon Lee; Hyunju Lee
Journal:  BMC Cancer       Date:  2017-05-15       Impact factor: 4.430

4.  Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature.

Authors:  Maryam Maghbool; Mani Ramzi; Inga Nagel; Pablo Bejarano; Reiner Siebert; Abolfazl Saeedzadeh; Yahya Daneshbod
Journal:  BMC Clin Pathol       Date:  2013-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.